Dorcas Beulah Chandramathy Gandhi

Dorcas Beulah Chandramathy Gandhi

Auto-generated profile, based on publicly available information

Dorcas Beulah Chandramathy Gandhi

Department of Neurology and College of Physiotherapy, Christian Medical College and Hospital, Ludhiana, India

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2018 in The Lancet
Verified
Journal Article
Closed access
JPJeyaraj D Pandian
Jeyaraj D Pandian
SGSeana L Gall
Seana L Gall
MKMahesh Kate
Mahesh Kate
GSGisele S Silva
Gisele S Silva
RARufus O Akinyemi
Rufus O Akinyemi
ATAmanda G Thrift
Amanda G Thrift

1 February 2020 in Therapeutics and Clinical Risk Management
Verified
Journal Article
Open access
PDF file
DGDorcas Bc Gandhi
Dorcas Bc Gandhi
ASAlbert Sterba
Albert Sterba
HKHimani Khatter
Himani Khatter
JPJeyaraj D Pandian
Jeyaraj D Pandian
In contrast to varied therapy approaches, mirror therapy (MT) can be used even in completely plegic stroke survivors, as it uses visual stimuli for producing a desired response in the affected limb. MT has been studied to have effects not just on motor impairments but also on sensations, visuospatial neglect, and pain after stroke. This paper attempts to systematically review and present the current perspectives on mirror therapy and its application in stroke rehabilitation, and dosage, feasibility and acceptability in stroke rehabilitation. An electronic database search across Google, PubMed, Web of Science, etc., generated 3871 results. After screening them based on the inclusion and exclusion criteria, we included 28 studies in this review. The data collected were divided on the basis of application in stroke rehabilitation, modes of intervention delivery, and types of control and outcome assessment. We found that most studies intervened for upper limb motor impairments post stroke. Studies were equally distributed between intervention in chronic and acute phases post stroke with therapy durations lasting between 1 and 8 weeks. MT showed definitive motor and sensory improvements although the extent of improvements in sensory impairments and hemineglect is limited. MT proves to be an effective and feasible approach to rehabilitate post-stroke survivors in the acute, sub-acute, and chronic phases of stroke, although its long-term effects and impact on activities of daily living need to be analysed extensively.

9 October 2023 in The Lancet Regional Health - Southeast Asia
Verified
Journal Article
Open access
JPJeyaraj D. Pandian
Jeyaraj D. Pandian
MSMadakasira Vasantha Padma Srivastava
Madakasira Vasantha Padma Srivastava
SASanjith Aaron
Sanjith Aaron
URUdaya K. Ranawaka
Udaya K. Ranawaka
NVNarayanaswamy Venketasubramanian
Narayanaswamy Venketasubramanian
YKYogeshwar V. Kalkonde
Yogeshwar V. Kalkonde
The World Health Organization (WHO) South East Asia Region (SEAR) comprises 11 countries, which are one of the most culturally, topographically, and socially diverse areas worldwide, undergoing an epidemiological transition towards non-communicable diseases, including stroke and other cardiovascular diseases (CVDs). This region accounts for over 40% of the global stroke mortality. Few well-designed population-based epidemiological studies on stroke are available from SEAR countries, with considerable variations among them. Ischemic stroke, a common stroke subtype, has higher frequencies of intracerebral hemorrhage in many countries. Along with an aging population, the increased prevalence of risk factors such as hypertension, diabetes mellitus, tobacco and alcohol consumption, lack of physical activity, high ambient pollution, heat, and humidity contribute to the high burden of stroke in this region. SEAR's many unique and uncommon stroke etiologies include cerebral venous thrombosis, tuberculosis, dengue, scrub typhus, falciparum malaria, snake bite, scorpion sting, etc. Current data on stroke burden and risk factors is lacking, compelling an urgent need for high-quality hospital-level and population-level data in all SEAR countries. Strategies towards a consolidated approach for implementing improved stroke prevention measures, stroke surveillance, and established stroke systems of care are the path to bridging the gaps in stroke care.

1 November 2019 in Stroke
Verified
Journal Article
Closed access
PDF file
JBJanet Prvu Bettger
Janet Prvu Bettger
CLChelsea Liu
Chelsea Liu
DGDorcas B.C. Gandhi
Dorcas B.C. Gandhi
PSP.N. Sylaja
P.N. Sylaja
NJNitha Jayaram
Nitha Jayaram
JPJeyaraj Durai Pandian
Jeyaraj Durai Pandian

9 October 2023 in The Lancet Regional Health - Southeast Asia
Verified
Journal Article
Open access
ISIvy A. Sebastian
Ivy A. Sebastian
DGDorcas B.C. Gandhi
Dorcas B.C. Gandhi
PSPadmavati N. Sylaja
Padmavati N. Sylaja
RPRaju Paudel
Raju Paudel
YKYogeshwar V. Kalkonde
Yogeshwar V. Kalkonde
JPJeyaraj D. Pandian
Jeyaraj D. Pandian
The Southeast Asia Region (SEAR) accounts for nearly 50% of the developing world's stroke burden. With various commonalities across its countries concerning health services, user awareness, and healthcare-seeking behavior, SEAR still presents profound diversities in stroke-related services across the continuum of care. This review highlights the numerous systems and challenges in access to stroke care, acute stroke care services, and health care systems, including rehabilitation. The paper has also attempted to compile information on the availability of stroke specialized centers, Intravenous thrombolysis (IVT) ready centers, Endovascular therapy (EVT) ready centers, rehabilitation centers, and workforce against a backdrop of each country's population. Lastly, the efforts of WHO (SEARO)-CMCL (World Health Organization-South East Asia region, Christian Medical College & Hospital Ludhiana) collaboration towards improving stroke services and capacity among the SEAR have been described.

15 June 2025 in International Journal of Stroke
Verified
Journal Article
Open access
NENicholas Richard Evans
Nicholas Richard Evans
JPJoão Pinho
João Pinho
LBLucy Beishon
Lucy Beishon
TNTu Nguyen
Tu Nguyen
AGAravind Ganesh
Aravind Ganesh
RLRichard I Lindley
Richard I Lindley
Frailty is common in stroke and has important disease- and treatment-modifying effects. The need to develop clinical practice and research for the impact of frailty on stroke is likely to increase in the coming decades as the global population ages, resulting in a higher burden of frailty that is likely to be borne disproportionately by lower- and middle-income countries. The global nature of frailty in stroke necessitates global action. This World Stroke Organization Scientific Statement synthesizes the current evidence relating to the prevalence and effects of frailty across the stroke pathway. Furthermore, it includes expert consensus on priority areas from a global panel: standardization of frailty assessments for research, explicit measurements of frailty (in addition to disability) in large clinical trials, dedicated studies investigating the treatment-modifying effects of frailty in acute stroke and secondary prevention, research investigating the impact of frailty on the different aspects of recovery and rehabilitation after stroke, and understanding the mechanisms underpinning the relationship between frailty and stroke for potential therapeutic exploitation. This scientific statement has been reviewed and approved by the World Stroke Organization Executive.